Emblem Corp.: Trading Deferred
(firmenpresse) - TORONTO, ONTARIO -- (Marketwired) -- 12/09/16 -- Emblem Corp. announced today that final regulatory approval of the trading date for its shares on the TSXV, originally announced as December 9, 2016, has been deferred. The likely trading date will be December 12, 2016. Emblem will issue an additional press release confirming its trading date during business hours on December 9.
Trading will take place on the TSX-V under the symbol EMC.V.
About Emblem Cannabis Corp.
Emblem Cannabis Corporation, a wholly-owned subsidiary of Emblem Corp. is a fully integrated Canadian medical marijuana, healthcare and cannabinoid-based pharmaceutical company licensed to carry on business as a producer of medical cannabis by the Government of Canada.
Contacts:
Investor Relations Contact:
Danny Brody
Director, Investor Relations
647-255-8106
Media Contact:
Jeff Silverstein
Sussex Strategy Group
416-879-4353
Themen in dieser Pressemitteilung:
Unternehmensinformation / Kurzprofil:
Datum: 09.12.2016 - 08:15 Uhr
Sprache: Deutsch
News-ID 1474819
Anzahl Zeichen: 2804
contact information:
Contact person:
Town:
TORONTO, ONTARIO
Phone:
Kategorie:
Alternative
Typ of Press Release:
type of sending:
Date of sending:
Anmerkungen:
Diese Pressemitteilung wurde bisher 249 mal aufgerufen.
Die Pressemitteilung mit dem Titel:
"Emblem Corp.: Trading Deferred
"
steht unter der journalistisch-redaktionellen Verantwortung von
Emblem Corp. (Nachricht senden)
Beachten Sie bitte die weiteren Informationen zum Haftungsauschluß (gemäß TMG - TeleMedianGesetz) und dem Datenschutz (gemäß der DSGVO).
